johannesburg, 13 th august 2009 outstanding business action to stop tb: how companies contribute to...
Post on 16-Jan-2016
216 Views
Preview:
TRANSCRIPT
Johannesburg, 13th August 2009
Outstanding Business Action to Stop TB: How Companies Contribute
to the Global Fight2009 TB Case Studies
Shuma PanseGlobal Business Coalition on HIV/AIDS, TB and Malaria (New York office)
GBC Case Studies
2
GBC Case Studies:
• Inspire readers with unique programs and innovative leveraging of core competencies
• Motivate by documenting concrete and measurable program outcomes
• Provide action-oriented guidance and critical success factors
• Grouped by industry or intervention type for target audiences
GBC identifies, collects, synthesizes and disseminates best practices in private sector engagement on HIV, TB and malaria
Case Study Collections
3
Current Publications
GBC Awards for Business Excellence (Annual Winner Profiles)
Travel & Tourism: Guidebook and Case Studies
In Good Company: How Business Fights the Feminization of HIV/AIDS
Outstanding Business Action to Stop TB: How Companies Contribute to the Global Fight
Coming Soon: Malaria Case Studies Publication (in partnership with the World Economic Forum)
4
Online Case Studies
Companies’ Response to Engagement in activities around tuberculosis
TB information and education
Strategies to prevent transmission in workplace &/or community
Integration of TB &HIV activities
Treatment regimen in line with NTP and Int'l Standards (DOT)
Early identification of TB suspects and prompt diagnosis
Only 40% of companies surveyed offer TB information and education in the workplace (n=83)
Why TB Case Studies?
6
Outstanding Business Action to Stop TB: Who, What & Why
Every industry has a role to play in tackling
TB!
Four Action AreasWorkplace
Community
Core Competence
Advocacy
Eli Lilly X XChevron X X XAstraZeneca X XOgilvy Healthworld
X X
BD X XAnglogold Ashanti
X
Bayer Healthcare
X
Barrick Gold X X
Though the type of intervention, scale and outcome of each program may vary, all of them share the following elements:
• Corporate commitment to stopping TB• Initial focus on risk assessment• Integrated approach to disease management• Partnerships with TB stakeholders
Diverse Programs With Shared Elements
Each case study includes:
9
BUSINESS OVERVIEW
PROGRAM DESCRIPTION
CRITICAL SUCCESS FACTORS
Advocacy Profile:
• Health Communications & Marketing Competencies
• Message Mapping for HIV & TB
R&D Profile:
• Assess the use of moxifloxacin in the treatment of TB
• Partnership with the TB Alliance for Drug Development
GBC TB Tools & Resources
2009 TB Case Studies
Issue Briefs
M&E CD-ROM
Together, we can Stop TB
Photo Credit: James Nachtwey (www.XDRTB.org)
top related